<VariationArchive VariationID="2990" VariationName="NM_000543.5(SMPD1):c.996del (p.Phe333fs)" VariationType="Deletion" Accession="VCV000002990" Version="29" RecordType="classified" NumberOfSubmissions="12" NumberOfSubmitters="12" DateLastUpdated="2024-06-17" DateCreated="2013-04-04" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18029" VariationID="2990">
      <GeneList>
        <Gene Symbol="SMPD1" FullName="sphingomyelin phosphodiesterase 1" GeneID="6609" HGNC_ID="HGNC:11120" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="6390474" stop="6394996" display_start="6390474" display_stop="6394996" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="6411643" stop="6416227" display_start="6411643" display_stop="6416227" Strand="+" />
          </Location>
          <OMIM>607608</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000543.5(SMPD1):c.996del (p.Phe333fs)</Name>
      <CanonicalSPDI>NC_000011.10:6392055:CCCCCC:CCCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="6392056" stop="6392056" display_start="6392056" display_stop="6392056" variantLength="1" positionVCF="6392055" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="6413286" stop="6413286" display_start="6413286" display_stop="6413286" variantLength="1" positionVCF="6413285" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>fsp330</Name>
        <Name>fsP330</Name>
      </OtherNameList>
      <ProteinChange>F332fs</ProteinChange>
      <ProteinChange>F333fs</ProteinChange>
      <ProteinChange>P12fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000543.4" sequenceAccession="NM_000543" sequenceVersion="4" change="c.996del">
            <Expression>NM_000543.4:c.996del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.6392061del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.6392061del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.6413291del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.6413291del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011780.1" sequenceAccession="NG_011780" sequenceVersion="1" change="g.6637del">
            <Expression>NG_011780.1:g.6637del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000543.5" sequenceAccession="NM_000543" sequenceVersion="5" change="c.996del" MANESelect="true">
            <Expression>NM_000543.5:c.996del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000534.3" sequenceAccession="NP_000534" sequenceVersion="3" change="p.Phe333fs">
            <Expression>NP_000534.3:p.Phe333fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001007593.3" sequenceAccession="NM_001007593" sequenceVersion="3" change="c.993del">
            <Expression>NM_001007593.3:c.993del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001007594.2" sequenceAccession="NP_001007594" sequenceVersion="2" change="p.Phe332fs">
            <Expression>NP_001007594.2:p.Phe332fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318087.2" sequenceAccession="NM_001318087" sequenceVersion="2" change="c.996del">
            <Expression>NM_001318087.2:c.996del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305016.1" sequenceAccession="NP_001305016" sequenceVersion="1" change="p.Phe333fs">
            <Expression>NP_001305016.1:p.Phe333fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318088.2" sequenceAccession="NM_001318088" sequenceVersion="2" change="c.35del">
            <Expression>NM_001318088.2:c.35del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305017.1" sequenceAccession="NP_001305017" sequenceVersion="1" change="p.Pro12fs">
            <Expression>NP_001305017.1:p.Pro12fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365135.2" sequenceAccession="NM_001365135" sequenceVersion="2" change="c.996del">
            <Expression>NM_001365135.2:c.996del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352064.1" sequenceAccession="NP_001352064" sequenceVersion="1" change="p.Phe333fs">
            <Expression>NP_001352064.1:p.Phe333fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_027400.3" sequenceAccession="NR_027400" sequenceVersion="3" change="n.1121del">
            <Expression>NR_027400.3:n.1121del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA252521" DB="ClinGen" />
        <XRef ID="GTR000321633" DB="Genetic Testing Registry (GTR)" />
        <XRef ID="GTR000603989" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="607608.0011" DB="OMIM" />
        <XRef Type="rs" ID="387906289" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000543.5(SMPD1):c.996del (p.Phe333fs) AND Niemann-Pick disease, type A" Accession="RCV000003124" Version="12">
        <ClassifiedConditionList TraitSetID="758">
          <ClassifiedCondition DB="MedGen" ID="C0268242">Niemann-Pick disease, type A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-25" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.996del (p.Phe333fs) AND Sphingomyelin/cholesterol lipidosis" Accession="RCV000192223" Version="7">
        <ClassifiedConditionList TraitSetID="8114">
          <ClassifiedCondition DB="MedGen" ID="C0028064">Sphingomyelin/cholesterol lipidosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-01-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.996del (p.Phe333fs) AND not provided" Accession="RCV000723827" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2020-07-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.996del (p.Phe333fs) AND Niemann-Pick disease, type B" Accession="RCV000984010" Version="2">
        <ClassifiedConditionList TraitSetID="759">
          <ClassifiedCondition DB="MedGen" ID="C0268243">Niemann-Pick disease, type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-09-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.996del (p.Phe333fs) AND multiple conditions" Accession="RCV000817028" Version="8">
        <ClassifiedConditionList TraitSetID="9472">
          <ClassifiedCondition DB="MedGen" ID="C0268242">Niemann-Pick disease, type A</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268243">Niemann-Pick disease, type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-28" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-25" NumberOfSubmissions="12" NumberOfSubmitters="12" DateCreated="2013-04-04" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12369017</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15221801</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15877209</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16642440</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21502868</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23252888</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23535491</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26169695</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29995201</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8401540</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9266408</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SMPD1</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/90e63163-d993-46b8-bea9-d9957e8f750e</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301544</ID>
          <ID Source="BookShelf">NBK1370</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="759" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3636" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type B</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+B/5227" DB="Genetic Alliance" />
                <XRef ID="39390005" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10729" />
                <XRef ID="10729" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77293" DB="Orphanet" />
              <XRef ID="C0268243" DB="MedGen" />
              <XRef ID="MONDO:0011871" DB="MONDO" />
              <XRef Type="MIM" ID="607616" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8114" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14993" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Niemann-Pick disease</ElementValue>
                <XRef ID="MONDO:0001982" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sphingomyelin/cholesterol lipidosis</ElementValue>
                <XRef ID="Niemann-Pick+disease/5222" DB="Genetic Alliance" />
                <XRef ID="58459009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13334" />
                <XRef ID="13334" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="C0028064" DB="MedGen" />
              <XRef ID="MONDO:0001982" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9472" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3636" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type B</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+B/5227" DB="Genetic Alliance" />
                <XRef ID="39390005" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10729" />
                <XRef ID="10729" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77293" DB="Orphanet" />
              <XRef ID="C0268243" DB="MedGen" />
              <XRef ID="MONDO:0011871" DB="MONDO" />
              <XRef Type="MIM" ID="607616" DB="OMIM" />
            </Trait>
            <Trait ID="5650" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type A</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+A/5226" DB="Genetic Alliance" />
                <XRef ID="52165006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELIN LIPIDOSIS</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELINASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7206" />
                <XRef ID="7206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000506506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77292" DB="Orphanet" />
              <XRef ID="C0268242" DB="MedGen" />
              <XRef ID="MONDO:0009756" DB="MONDO" />
              <XRef Type="MIM" ID="257200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="758" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5650" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type A</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+A/5226" DB="Genetic Alliance" />
                <XRef ID="52165006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELIN LIPIDOSIS</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELINASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7206" />
                <XRef ID="7206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000506506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77292" DB="Orphanet" />
              <XRef ID="C0268242" DB="MedGen" />
              <XRef ID="MONDO:0009756" DB="MONDO" />
              <XRef Type="MIM" ID="257200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1363772" SubmissionDate="2018-01-25" DateLastUpdated="2015-06-28" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="NM_000543.4:c.996delC|MedGen:C0268242" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000697420" DateUpdated="2015-06-28" DateCreated="2015-06-28" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8401540</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23535491</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26169695</ID>
          </Citation>
          <Comment>Variant summary: The SMPD1 c.996delC (p.Phe333Serfs) variant results in a premature termination codon, predicted to cause a truncated or absent SMPD1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One in silico tool predicts a damaging outcome for this variant. This variant was found in 31/144104 control chromosomes at a frequency of 0.0002151, which does not exceed the estimated maximal expected allele frequency of a pathogenic SMPD1 variant (0.0022361). This variant has been reported in multiple NPDA patients and has been reported as one of the founder SMPD1 Ashkenazi mutations. This variant has also been reported in patients with Parkinson disease and was suggested to possibly contribute to PD. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="387906289" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.4:c.996delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268242" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="415459" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="16098_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000227143" DateUpdated="2018-12-15" DateCreated="2015-06-28" Type="SCV" Version="5" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-12-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="-" referenceAllele="C" start="6413291" stop="6413291" variantLength="1" />
            <GeneLocation>NM_000543.4:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD931053" />
            <XRef DB="dbSNP" ID="387906289" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SMPD1</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="23282" SubmissionDate="2021-06-24" DateLastUpdated="2021-07-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607608.0011_NIEMANN-PICK DISEASE, TYPE A" title="SMPD1, 1-BP DEL, PRO330FS_NIEMANN-PICK DISEASE, TYPE A" />
        <ClinVarAccession Accession="SCV000023282" DateUpdated="2021-07-07" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1993-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Levran et al. (1993) described a new mutation that causes type A Niemann-Pick disease (257200) in Ashkenazi Jewish patients. Deletion of a single cytosine in codon 330 of the SMPD1 cDNA (which normally encodes a proline residue) caused a frameshift that led to the formation of a premature stop (TGA) at codon 382. The mutation occurred in 4 of 52 SMPD1 alleles analyzed from unrelated Ashkenazi Jewish type A patients or obligate heterozygotes. In contrast, the mutation was not found in non-Jewish type A patients or in any Jewish or non-Jewish type B patients. Three mutations, R496L (607608.0001), L302P (607608.0010), and this mutation, account for about 65% of the mutant SMPD1 alleles in Ashkenazi Jewish type A Niemann-Pick disease patients. The single base deletion causing the pro330FS mutation was in a region of the gene where 9 of the 10 residues were cytosines.</Attribute>
              <Citation>
                <ID Source="PubMed">8401540</ID>
              </Citation>
              <XRef DB="OMIM" ID="257200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <Name>SMPD1, 1-BP DEL, PRO330FS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, PRO330FS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607608.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NIEMANN-PICK DISEASE, TYPE A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2804966" SubmissionDate="2020-03-09" DateLastUpdated="2022-02-02" DateCreated="2020-07-19">
        <ClinVarSubmissionID localKey="90e63163-d993-46b8-bea9-d9957e8f750e|MedGen:C0028064" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001422555" DateUpdated="2022-02-02" DateCreated="2020-07-19" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12369017</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9266408</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29995201</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15877209</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8401540</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/90e63163-d993-46b8-bea9-d9957e8f750e</URL>
          </Citation>
          <Comment>The p.Phe333SerfsTer52 variant in SMPD1 (also known as p.Phe331SerfsTer52 due to a difference in cDNA numbering) has been reported in at least 9 individuals with Niemann-Pick disease, segregated with disease in 3 individuals from 1 family (PMID: 15877209, 9266408, 29995201, 8401540, 12369017), and has been identified in 0.129% (13/10078) of Ashkenazi Jewish chromosomes and 0.001% (1/113702) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs387906289). Although this variant has been seen in the general population, its frequency is consistent with the increased carrier rate in the Ashkenazi Jewish population and is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (VariationID: 2990) as pathogenic by Counsyl, EGL Genetic Diagnostics, GeneReviews, Integrated Genetics, and OMIM. In vitro functional studies provide some evidence that the p.Phe333Serfs variant may impact protein function (PMID: 15877209; 9266408). However, these types of assays may not accurately represent biological function. This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 333 and leads to a premature termination codon 52 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Although this variant causes loss of function, it is pathogenic without the use of PVS1 and was used to establish whether loss of function is a mechanism of disease. The phenotype of individuals compound heterozygous for this variant is highly specific for Niemann-Pick disease based on acid sphingomyelinase activity being &lt;10%, consistent with disease (PMID: 15877209). The presence of this variant in combination with reported pathogenic or likely pathogenic variants in at least 7 individuals with Niemann-Pick disease increases the likelihood that the p.Phe333Serfs variant is pathogenic (VariationID: 198093, 2980; PMID: 15877209, 9266408, 29995201, 8401540, 12369017). In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on its presence in trans with other pathogenic variants in affected individuals, in vitro functional studies, cosegregation, and the phenotype of patients with the variant being highly specific for disease. ACMG/AMP Criteria applied: PM3_very-strong, PS3_moderate, PP1, PP4 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Abbrev="ACMG, 2015" Type="practice guideline">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000543.4(SMPD1):c.996delC</Name>
            <Name>p.Phe333Serfs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.10:g.6392061delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Sphingomyelin/cholesterol lipidosis</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0028064" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6906750</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4079739" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000543.5:c.996del|Niemann-Pick Disease, Types A/B" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002092257" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.5:c.996del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Niemann-Pick Disease, Types A/B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="440555" SubmissionDate="2021-11-23" DateLastUpdated="2022-10-01" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_000543.3:c.996delC|MedGen:C0028064" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000238490" DateUpdated="2022-10-01" DateCreated="2015-10-05" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8401540</ID>
          </Citation>
          <Comment>1 of 3 common variants that accounts for more than 90% of pathogenic variants in persons of Ashkenazi Jewish ancestry with Niemann-Pick disease type-A</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.3:c.996delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0028064" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10713096</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3965607" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="226d79a1427f407380cb14ec67a0f34c75e0a8315ab8dc2db31c404100025d0e|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002020762" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.5:c.996del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1329143" SubmissionDate="2019-08-05" DateLastUpdated="2019-12-23" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="561|OMIM:607616" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000677985" DateUpdated="2019-12-23" DateCreated="2015-06-28" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-09-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9266408</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8401540</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23252888</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16642440</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21502868</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="T" referenceAllele="TC" start="6413285" stop="6413286" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607616" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354437" SubmissionDate="2020-01-15" DateLastUpdated="2020-04-06" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey=":Chr.11_6413285_6413286_TC_T|OMIM:257200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001193982" DateUpdated="2020-04-06" DateCreated="2020-04-06" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9266408</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23252888</ID>
          </Citation>
          <Comment>NM_000543.4(SMPD1):c.996delC(aka fsP330) is classified as pathogenic in the context of Niemann-Pick disease. Sources cited for classification include the following: 9266408 and 23252888. Classification of NM_000543.4(SMPD1):c.996delC(aka fsP330) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="T" referenceAllele="TC" start="6413285" stop="6413286" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="257200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5468489" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000543.5:c.996del|OMIM:257200;607616" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002816526" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.5:c.996del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="257200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607616" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1851811" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="2602953|MedGen:C0268243;C0268242" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000957564" DateUpdated="2024-02-28" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12369017</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15221801</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8401540</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe333Serfs*52) in the SMPD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMPD1 are known to be pathogenic (PMID: 12369017, 15221801). This variant is present in population databases (rs772960412, gnomAD 0.1%). This premature translational stop signal has been observed in individuals with Niemann-Pick disease (PMID: 8401540). ClinVar contains an entry for this variant (Variation ID: 2990). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.6413286del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268243" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268242" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7854187" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000543.5:c.996del|OMIM:257200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004203206" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.5:c.996del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="257200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="415459" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1851811" TraitType="Disease" MappingType="XRef" MappingValue="C0268242" MappingRef="MedGen">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="440555" TraitType="Disease" MappingType="XRef" MappingValue="C0028064" MappingRef="MedGen">
        <MedGen CUI="C0028064" Name="Sphingomyelin/cholesterol lipidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354437" TraitType="Disease" MappingType="XRef" MappingValue="257200" MappingRef="OMIM">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4079739" TraitType="Disease" MappingType="Name" MappingValue="Niemann-Pick Disease, Types A/B" MappingRef="Preferred">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1363772" TraitType="Disease" MappingType="XRef" MappingValue="C0268242" MappingRef="MedGen">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468489" TraitType="Disease" MappingType="XRef" MappingValue="257200" MappingRef="OMIM">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1851811" TraitType="Disease" MappingType="XRef" MappingValue="C0268243" MappingRef="MedGen">
        <MedGen CUI="C0268243" Name="Niemann-Pick disease, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2804966" TraitType="Disease" MappingType="Name" MappingValue="Sphingomyelin/cholesterol lipidosis" MappingRef="Preferred">
        <MedGen CUI="C0028064" Name="Sphingomyelin/cholesterol lipidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3965607" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468489" TraitType="Disease" MappingType="XRef" MappingValue="607616" MappingRef="OMIM">
        <MedGen CUI="C0268243" Name="Niemann-Pick disease, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7854187" TraitType="Disease" MappingType="XRef" MappingValue="257200" MappingRef="OMIM">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1329143" TraitType="Disease" MappingType="XRef" MappingValue="607616" MappingRef="OMIM">
        <MedGen CUI="C0268243" Name="Niemann-Pick disease, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23282" TraitType="Disease" MappingType="Name" MappingValue="NIEMANN-PICK DISEASE, TYPE A" MappingRef="Preferred">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

